preview check box set
bottom line medtron report may et
passcod provid anoth line sight compani progress
importantli guidanc earn print quickli follow
june analyst day nyc expect full updat product pipelin
focu therapi innov meantim model revenu
organ ep top end manag
rang line consensu
start revenu estim ex-fx
organ includ cardiac vascular sale organ
minim invas therapi sale organ restor
therapi sale ex-fx diabet sale
ex-fx quarter would expect diabet continu acceler
would also expect strong european tavr sale given edward lifesci
commentari model ou corevalv sale look stabil
spine franchis model spine flat turn expens
model gross margin vs y/i pro forma sg vs
 vs combin look oper margin vs
look forward manag alreadi provid guardrail
includ mid-single-digit revenu growth driven mid-single-digit growth
cvg mitg rtg franchis augment strong double-digit growth
diabet oper leverag remain core focu particularli enterpris
excel plan well way manag continu expect high-single-
digit constant currenc ep growth addit commentari call
indic less interest incom anniversari benefit chang
account stock-bas compens well begin transit servic
relat cardin divestitur combin could amount
hundr basi point headwind offset benefit shift
fx
given compani file updat model ad pro
forma column lower ep estim
maintain rate share outperform
research help appreci consider
pleas refer page import disclosur includ analyst certif
therapi diabet franchis along
healthi cash flow dividend yield valuat
make compel invest
good sold
sale
 sale
chang incl fx impact
given steadi revenu growth rate combin
healthi cash flow dividend yield set price-to-earnings
multipl growth compani valu
product launch heart valv
segment expand respect market
face stiffer competit market
stent tavr market fail fulli captur
expect synergi relat covidien acquisit
usd
expect launch guardian connect
continu glucos monitor
evolut tavr system japan
diversifi compani focus
cardiovascular spine neuromodul diabet
product includ icd pacemak diagnost
monitor devic electrophysiolog system
cardiovascular product includ coronari peripher
stent valv replac product stent graft
exhibit medtron quarterli incom statement fiscal year end april million except per-shar good expens incom includ mt interest expens ep w/ option net ep w/ option w/ analysisnet margin percentag chang sequenti net gross oper pre-tax net chang annual net net sale net sale gross oper pre-tax net ep w/ option ex- bmo capit market estim corpor
medtron rate histori
medtron rate histori
